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Introduction: Corneal endothelial damage and 
diseases are two of the major contributors to 
blindness or severe visual impairment 
worldwide[1]. The corneal endothelium is the 
innermost cell layer of the cornea and consists 
of a monolayer of hexagonal cells that maintain 
the stroma in a state of relative dehydration 
through a “pump-and-leak” mechanism. A 
critical loss of cells due to damage, disease or 
aging leads to corneal edema which in turn 
results in opacification of the cornea [2]. 
Currently, the only treatment consists of a 
(partial) corneal transplantation from healthy 
cadaveric donor tissue. Unfortunately,  only 1 
donor is available for every 70 cases [3]. To 
tackle this donor shortage, the present work 
focusses on the development of transparent 
(>90%), thin (≤5µm), multilayered sheets 
constituting a poly(D,L-lactide) (PDLLA) layer 
for structural rigidity and a crosslinkable 
gelatin-based hydrogel as an extracellular 
matrix (ECM) mimic. These sheets provide a 
supporting function for corneal endothelial 
cells to enable subsequent ocular implantation 
thereby restoring the damaged endothelium and 
patient’s vision. 
Methods: Multi-layered sheets (ø = 12mm) 
were developed through successive spincoating 
steps. A sacrificial gelatin layer (H2O, 10w/v%) 
was spincoated on a glass plate followed by a 
PDLLA (Corbion, PURASORB PDL20) layer 
for structural integrity (THF, 4w/w%). Next, a 
layer of one of the  crosslinkable gelatin 
derivatives, crosslinkable gelatin derivatives, 
gelatin-methacrylamide (Gel-MA), gelatin-
methacrylamide- amino-ethylmethacrylate 
(Gel-MA-AEMA) [4] and gelatin-norbornene 
(Gel-NB) [5], is  spincoated (H2O, 10w/v%) as 
final layer, after applying an argon plasma 
treatment (0.8mbar, 30s) to the PDLLA. 
Finally, crosslinkable gelatin was crosslinked 
using UV-A (6 mW/cm2, 30 min) irradiation. 
Isolation of the sheets occurred by immersing 
in warm water (40°C), thereby dissolving the 
sacrificial gelatin layer. The sheets were 
characterized for their transparency (UV-
VIS/NIR, 390-700 nm), thickness (white light 
interferometry) and glucose permeability (side-
by side diffusion setup, glucose assay kit) as 
well as for their surface composition (XRD) 
and compatibility with corneal endothelial cells 
using both primary and B4G12 cells.  
Results: Multi-layered sheets were 
successfully produced. The sheet thicknesses 
ranged between 0.8 and 1.5µm which is thinner 
than the natural Descemet’s membrane (i.e. 10-
20µm). All produced sheets showed a 
transparency of over >95% in dry state and > 
98% in the wet state throughout the visual 
spectrum with no significant differences 
observed between the applied gelatin 
derivatives. The sheets were sufficiently 
permeable (>2.36*10-3 cm/s) towards glucose, 
both in the presence and absence of the gelatin-
derived coating. Upon seeding of the sheets 
with B4G12 cells and primary corneal 
endothelial cells, the cells developed their 
characteristic hexagonal shape. 
Immunocytochemical staining confirmed the 
presence of Na+/K+ ATPase pumps and tight 
junctions (ZO-1), indicating good cellular 
proliferation. 
Conclusion: Transparent (>90%), thin (<10 
µm), multi-layered sheets were successfully 
produced. These sheets were sufficiently 
permeable for glucose. Additionally, the sheets 
were able to support the proliferation of B4G12 
and primary corneal endothelial cells. The 
produced sheets are thus promising candidates 
to function as tissue engineered alternatives for 
donor corneas. 
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